Ryman Healthcare Limited (NZE:RYM)
New Zealand flag New Zealand · Delayed Price · Currency is NZD
2.140
-0.050 (-2.28%)
Jul 31, 2026, 5:00 PM NZST

Ryman Healthcare Cash Flow Statement

Millions NZD. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
-171.35-513.75-169.67257.84692.87
Depreciation & Amortization
42.5548.4635.3725.9730.59
Other Amortization
--10.6211.745.11
Asset Writedown & Restructuring Costs
100.6685.87135.63-420.47-745.89
Stock-Based Compensation
0.742.432.93--
Other Operating Activities
-19.01214.04-116.75103.2233.28
Change in Accounts Receivable
-0.07-5.6-21.98-46.55-129.02
Change in Inventory
-2.372.9411.630.39
Change in Accounts Payable
-11.167.68-2.0341.119.17
Change in Unearned Revenue
--41.5918.029.44
Change in Other Net Operating Assets
391.6568.74676.61639.43680.03
Operating Cash Flow
333.97410.25595.26641.95585.98
Operating Cash Flow Growth
-18.59%-31.08%-7.27%9.55%41.84%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-52.09-137.87-201.82-422.94-334.29
Sale of Property, Plant & Equipment
2.230.65-19.65-
Sale (Purchase) of Intangibles
-0.25-3.11-6.72-20.11-14.35
Sale (Purchase) of Real Estate
-97.86-387.83-575.41-608.78-434.4
Other Investing Activities
0.362.585.121.2-4.28
Investing Cash Flow
-147.62-525.58-778.83-1,031-787.31

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Long-Term Debt Issued
--201.22436.72326.92
Long-Term Debt Repaid
-195.35-885.45-3.37-752.12-2.66
Net Debt Issued (Repaid)
-195.35-885.45197.85-315.4324.26
Issuance of Common Stock
0.85976.52-2.64-
Repurchase of Common Stock
-----2.79
Common Dividends Paid
----68.09-112
Other Financing Activities
---0.35769.44-
Financing Cash Flow
-194.591.06197.5388.6209.47

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
0.190.12---
Net Cash Flow
-7.96-24.1513.93-0.438.14

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
281.88272.38393.44219.01251.68
Free Cash Flow Growth
3.49%-30.77%79.64%-12.98%60.80%
Free Cash Flow Margin
32.99%35.88%57.22%37.66%49.47%
Free Cash Flow Per Share
0.280.380.570.420.50
Levered Free Cash Flow
352.43337.19318.023,883-120.36
Unlevered Free Cash Flow
429.75426.43361.183,881-101.2

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
85.85127.136.7946.8629.24
Change in Working Capital
380.37573.19697.13663.64570.01